| For: | Liu XY, Guo CH, Xi ZY, Xu XQ, Zhao QY, Li LS, Wang Y. Histone methylation in pancreatic cancer and its clinical implications. World J Gastroenterol 2021; 27(36): 6004-6024 [PMID: 34629816 DOI: 10.3748/wjg.v27.i36.6004] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i36/6004.htm |
| Number | Citing Articles |
| 1 |
Krzysztof Szymoński, Katarzyna Skirlińska-Nosek, Ewelina Lipiec, Kamila Sofińska, Michał Czaja, Natalia Wilkosz, Matylda Krupa, Filip Wanat, Magdalena Ulatowska-Białas, Dariusz Adamek. Combined analytical approach empowers precise spectroscopic interpretation of subcellular components of pancreatic cancer cells. Analytical and Bioanalytical Chemistry 2023; 415(29-30) doi: 10.1007/s00216-023-04997-w
|
| 2 |
Krzysztof Szymoński, Natalia Janiszewska, Kamila Sofińska, Katarzyna Skirlińska-Nosek, Dawid Lupa, Michał Czaja, Marta Urbańska, Katarzyna Jurkowska, Kamila Konik, Marta Olszewska, Dariusz Adamek, Kamil Awsiuk, Ewelina Lipiec. Spatial recognition and semi-quantification of epigenetic events in pancreatic cancer subtypes with multiplexed molecular imaging and machine learning. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-90087-z
|
| 3 |
Farah Ahmady-Nield, Rodney B. Luwor, George Kannourakis. Mechanisms of Immune Cell Dysregulation in Pancreatic Ductal Adenocarcinoma. Biology 2026; 15(18) doi: 10.3390/biology15181599
|
| 4 |
Ebru Erzurumluoğlu Gökalp, Sevgi Işık, Sevilhan Artan. Cancer Epigenetics. Epigenetics and Human Health 2023; 11 doi: 10.1007/978-3-031-42365-9_3
|
| 5 |
Yuhao Zhao, Mao Yang, Shijia Wang, Sk Jahir Abbas, Junzhe Zhang, Yongsheng Li, Rong Shao, Yingbin Liu. An Overview of Epigenetic Methylation in Pancreatic Cancer Progression. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.854773
|
| 6 |
Marzieh Jamali, Erfaneh Barar, Jiaqi Shi. Unveiling the Molecular Landscape of Pancreatic Ductal Adenocarcinoma: Insights into the Role of the COMPASS-like Complex. International Journal of Molecular Sciences 2024; 25(10) doi: 10.3390/ijms25105069
|
| 7 |
Lei Jin, Daohai Qian, Xiaolei Tang, Yong Huang, Junwei Zou, Zhaoying Wu. SMYD2 Imparts Gemcitabine Resistance to Pancreatic Adenocarcinoma Cells by Upregulating EVI2A. Molecular Biotechnology 2024; 66(10) doi: 10.1007/s12033-023-00908-7
|
| 8 |
Renzo Vera, María Julia Lamberti, Alina L. Gonzalez, Martín E. Fernandez-Zapico. Epigenetic regulation of the tumor microenvironment: A leading force driving pancreatic cancer. Pancreatology 2024; 24(6) doi: 10.1016/j.pan.2024.07.005
|
| 9 |
Chenhao Fu, Zhifang Jia, Yingli Fu, Yangyu Zhang, Yanhua Wu, Xueyuan Cao, Donghui Cao, Jing Jiang. The Clinical Prognostic Value of Lactylation-Regulated Proteins in Gastric Cancer. Journal of Proteome Research 2026; 25(1) doi: 10.1021/acs.jproteome.5c00813
|
| 10 |
Lei Yang, Qiqiong Zhang, Qiuye Yang. KDM3A promotes oral squamous cell carcinoma cell proliferation and invasion via H3K9me2 demethylation-activated DCLK1. Genes & Genomics 2022; 44(11) doi: 10.1007/s13258-022-01287-0
|
| 11 |
Yunxia Wang, Xiaolin Liu, Luyao Gong, Weihong Ding, Wenjing Hao, Yeheng Peng, Jun Zhang, Weimin Cai, Yuan Gao. Mechanisms of sunitinib resistance in renal cell carcinoma and associated opportunities for therapeutics. British Journal of Pharmacology 2023; 180(23) doi: 10.1111/bph.16252
|
| 12 |
Meng Shu, Yiying Jia, Shuwei Zhang, Bangyu Zou, Zhaoxin Ying, Xu Gao, Ziyu Fang, Xiaofeng Gao. Macrophage Reprogramming: Emerging Molecular Therapeutic Strategies for Nephrolithiasis. Biomolecules 2025; 15(8) doi: 10.3390/biom15081090
|
| 13 |
Leoncini Giuseppe, Barella Marco, Droz Dit Busset Michele, Gentili Marco, Bodini Beatrice, Ronchetti Simona, Cari Luigi, Mazzaferro Vincenzo. Aquaporin‐1 differentiates intrahepatic cholangiocarcinoma from liver metastases of pancreatic ductal adenocarcinoma. Histopathology 2026; 88(7) doi: 10.1111/his.70108
|
| 14 |
Jorg Tost, Secil Ak-Aksoy, Daniele Campa, Chiara Corradi, Riccardo Farinella, Alejandro Ibáñez-Costa, Juan Dubrot, Julie Earl, Emma Barreto Melian, Agapi Kataki, Georgina Kolnikova, Gjorgji Madjarov, Marija Chaushevska, Jan Strnadel, Miljana Tanić, Miroslav Tomas, Peter Dubovan, Maria Urbanova, Verona Buocikova, Bozena Smolkova. Leveraging epigenetic alterations in pancreatic ductal adenocarcinoma for clinical applications. Seminars in Cancer Biology 2025; 109 doi: 10.1016/j.semcancer.2025.01.003
|
| 15 |
Gengjun Zhu, Lifang Jin, Wanchun Sun, Shuang Wang, Ning Liu. Proteomics of post-translational modifications in colorectal cancer: Discovery of new biomarkers. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022; 1877(4) doi: 10.1016/j.bbcan.2022.188735
|
| 16 |
Immacolata Maietta, África González-Fernández, Rosana Simón-Vázquez. Harnessing epigenetic inhibitors: A promising approach for overcoming challenges in pancreatic ductal adenocarcinoma treatment. Advanced Drug Delivery Reviews 2025; 224 doi: 10.1016/j.addr.2025.115638
|
| 17 |
Eunji Hong, Wojciech Barczak, Sujin Park, Jin Sun Heo, Akira Ooshima, Shonagh Munro, Chang Pyo Hong, Jinah Park, Haein An, Joon Oh Park, Seok Hee Park, Nick B. La Thangue, Seong-Jin Kim. Combination treatment of T1-44, a PRMT5 inhibitor with Vactosertib, an inhibitor of TGF-β signaling, inhibits invasion and prolongs survival in a mouse model of pancreatic tumors. Cell Death & Disease 2023; 14(2) doi: 10.1038/s41419-023-05630-5
|
| 18 |
Abilash Navaneethan, Mrithika Ajay, Karnika Yogeswari Makesh, Ganesh Munuswamy-Ramanujam, Rameshbabu Boga, Dhanavathy Gnanasampanthapandian, Kanagaraj Palaniyandi. Exploring the Role of Histone Lysine Methyl Transferases in Pancreatic Cancer: A Review of Therapeutics and Clinical Implications. Journal of Endocrinology and Reproduction 2025; doi: 10.18311/jer/2024/49088
|
| 19 |
Sharath Mohan Bhat, Nischal L. Simha, Sanvi Hegde, Manjunath B. Joshi. Epigenetics of Cervical Cancer. 2025; doi: 10.1007/978-981-96-3985-4_6
|
| 20 |
John Kaszycki, Minji Kim. Epigenetic Drivers of Chemoresistance in Nucleobase and Nucleoside Analog Therapies. Biology 2025; 14(7) doi: 10.3390/biology14070838
|
| 21 |
Mohd Haris Jamal, Pratyush Porel, Khadga Raj Aran. Emerging biomarkers for pancreatic cancer: from early detection to personalized therapy. Clinical and Translational Oncology 2025; 27(11) doi: 10.1007/s12094-025-03947-5
|
| 22 |
Lei Zhu, Dong Tu, Ruixue Li, Lin Li, Wenjie Zhang, Wenxiang Jin, Tiehan Li, Hong Zhu. The diagnostic significance of the ZNF gene family in pancreatic cancer: a bioinformatics and experimental study. Frontiers in Genetics 2023; 14 doi: 10.3389/fgene.2023.1089023
|
| 23 |
Jia-Dan Zhou, Hong-Zhang Shen. Advances in pancreatic cancer epigenetics: From the mechanism to the clinic. World Journal of Gastrointestinal Oncology 2025; 17(7): 106238 doi: 10.4251/wjgo.v17.i7.106238
|
| 24 |
Farzaneh Amirmahani, Saurav Kumar, Sree Deepthi Muthukrishnan. Molecular Targets in Cancer Therapy. 2025; doi: 10.1007/978-981-96-7336-0_4
|
| 25 |
Suvasmita Rath, Diptesh Chakraborty, Jyotsnarani Pradhan, Mohammad Imran Khan, Jagneshwar Dandapat. Epigenomic interplay in tumor heterogeneity: Potential of epidrugs as adjunct therapy. Cytokine 2022; 157 doi: 10.1016/j.cyto.2022.155967
|
| 26 |
Kayla C. LaRue-Nolan, Glancis Luzeena Raja Arul, Ashley N. Sigafoos, Jiaqi Shi, Martin E. Fernandez-Zapico. Insights into the mechanisms driven by H3K4 KMTs in pancreatic cancer. Biochemical Journal 2024; 481(15) doi: 10.1042/BCJ20230374
|
| 27 |
Zhe Jia, Shan Lu, Zhenchuan Wang, Pengfei Ge. From mechanism to targeted therapy: Advances in histone lactylation‑driven cancer progression (Review). Oncology Letters 2025; 31(1) doi: 10.3892/ol.2025.15381
|
| 28 |
Fengye Liu, Longfei He, Muying Yu, Junyi Chen, Yuxiao Huang, Wenzhe Ma, Ying Wan, Bingru Zhou. Histone Modification Networks Reshape the Metabolism and Treatment Landscape of Urological Cancers. Frontiers in Bioscience-Landmark 2025; 30(11) doi: 10.31083/FBL42831
|
| 29 |
Luis Alberto Bravo-Vázquez, Natalia Frías-Reid, Ana Gabriela Ramos-Delgado, Sofía Madeline Osorio-Pérez, Hania Ruth Zlotnik-Chávez, Surajit Pathak, Antara Banerjee, Anindya Bandyopadhyay, Asim K. Duttaroy, Sujay Paul. MicroRNAs and long non-coding RNAs in pancreatic cancer: From epigenetics to potential clinical applications. Translational Oncology 2023; 27 doi: 10.1016/j.tranon.2022.101579
|
| 30 |
Mengxiao Wang, Junyi Liang, Xinping Zhu, Yushuang Xing, Shijun Chang, Di Jia, Weiming Zhao. Natural Plant Bioactives as Regulators of Histone Modifications: Bridging Epigenetics and Anticancer Therapy. Phytotherapy Research 2026; 40(8) doi: 10.1002/ptr.70386
|
| 31 |
Saranya Arumugam, C. Anjugam, R. Muthuvel, Gowtham Kumar Subbaraj. Epigenetic Regulations in Gastrointestinal Cancers. 2026; doi: 10.1016/B978-0-443-27765-8.00008-4
|